citation,pmid
"Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, et al. Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet. 2009 Oct;41(10):1127–32.",19718025
"Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, et al. Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet. 2011 Sep 25;43(11):1119–26.",21946352
"Postow MA, Carvajal RD. Therapeutic implications of KIT in melanoma. Cancer J. 2012;18(2):137–41.",22453014
"Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012 May 9;485(7399):502–6.",22622578
"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251–63.",22817889
"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006–14.",22842228
Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681–96.,26091043
"Kunz M, Vera J. Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers. Cancers (Basel). 2019 Apr 3;11(4):465.",30987166
